Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Walter W. Noll is active.

Publication


Featured researches published by Walter W. Noll.


Cancer | 2009

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

Michael J. Hall; Julia Reid; Lynn Anne Burbidge; Dmitry Pruss; Amie M. Deffenbaugh; Cynthia Frye; Richard J. Wenstrup; Brian E. Ward; Thomas Scholl; Walter W. Noll

In women at increased risk for breast and ovarian cancer, the identification of a mutation in breast cancer gene 1 (BRCA1) and BRCA2 has important implications for screening and prevention counseling. Uncertainty regarding the role of BRCA1 and BRCA2 testing in high‐risk women from diverse ancestral backgrounds exists because of variability in prevalence estimates of deleterious (disease‐associated) mutations in non‐white populations. In this study, the authors examined the prevalence of BRCA1 and BRCA2 mutations in an ethnically diverse group of women who were referred for genetic testing.


Cancer | 1980

Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung

Olive S. Pettengill; George D. Sorenson; Doris H. Wurster-Hill; Thomas J. Curphey; Walter W. Noll; Charles C. Gate; L. Herbert Maurer

Sixteen continuous tumor‐cell cultures have been isolated from 91 tissue specimens from patients with small‐cell carcinoma of the lung. Biopsy and autopsy specimens of primary and metastatic tumors have been utilized. The developing cell lines were recognized by proliferation of tumor cells in the culture from one to 14 weeks after explantation and have been maintained for up to four years. Primary lung tumor, bone marrow aspirations, pleural effusions and other metastases have all been productive explant material for the development of cell lines. Their human origin has been demonstrated by chromosome and/or isoenzyme analysis. Dense core vesicles, characteristically found in small‐cell tumor cells were observed by electron microscopic examination of cultured cells. Growth rates in vitro have been measured and the in vitro cycle time in tumors of one cell line (DMS 79) has been compared with in vivo cycle time in tumors arising from DMS 79 cells in nude athymic mice.


Cancer Letters | 1979

Transplantation of azaserine-induced carcinomas of pancreas in rats*

Daniel S. Longnecker; Herman S. Lilja; Janice French; Elna T. Kuhlmann; Walter W. Noll

Two pancreatic adenocarcinomas which had been induced in Wistar/Lewis rats by azaserine treatment were transplanted into rats of the same strain by subcutaneous and intraperitoneal injection of minced tumor. Subsequently, we have serially transplanted into non-radiated recipients. Transplanted tumors have maintained evidence of acinar cell differentiation including the presence of zymogen granules in tumors studied by electron microscopy, and of lipase, amylase and trypsin activity in the supernatant of tumor homogenates. Histologically, the tumors vary from poorly differentiated solid carcinomas to well differentiated variants which form acini. Transplanted tumors are locally invasive and have metastasized to lung and liver in some recipients.


Annals of Family Medicine | 2003

Factors Affecting the Detection Rate of Human Papillomavirus

Diane M. Harper; Meghan R. Longacre; Walter W. Noll; Dorothy R. Belloni; Bernard F. Cole

BACKGROUND Maximizing the accuracy of human papillomavirus (HPV) detection from a single sample is important for clinical and research purposes. The purpose of this study was to determine whether cyclic hormonal variation, recent sexual intercourse, interval between samplings, and the technique used to sample affect the detection of HPV. METHODS This study was a prospective, longitudinal, randomized controlled trial. Three techniques for self-sampling (2 consecutive synthetic polyester fiber [Dacron] swabs, a single Dacron swab, and a tampon) were repeated at 3 different sampling times during a period of 4 to 6 weeks in addition to 1 clinician-directed sampling of the ectocervix and endocervix at the first sampling time. All self-samplings were taken in a proscribed randomized order. Women (aged 18 to 68 years) attending a colposcopy clinic for abnormal cytology or abnormal cervical appearance participated in the study. The outcome measure was the detection of HPV by polymerase chain reaction amplification. RESULTS The 103 participants provided 1,189 cervicovaginal samplings. Logistic regression indicated that intercourse within 48 hours of sampling did not result in a greater detection of high-risk or any HPV type (odds ratio [OR] = 1.05, 95% confidence interval [CI], 0.65–1.69; OR = 1.08, 95% CI, 0.73–1.60, respectively). Among those women who have regular menstrual cycles, there was no cyclic effect on HPV detection for high-risk and any HPV types. Time from previous sampling did not affect HPV detection. Among the self-sampling techniques, using a single self-swab and the tampon resulted in the detection of HPV between 10% and 35% less often than using 2 consecutive swabs (P < .025). Self-sampling with 2 swabs was not significantly different from clinician sampling for detecting high-risk HPV types (OR for self-sampling = 0.87 (95% CI, 0.66–1.13)). CONCLUSIONS HPV detection is not dependent on menstrual cycle timings, the recency of intercourse, or the time between samplings, but it is dependent on the sampling technique.


Sexually Transmitted Diseases | 2002

Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus.

Diane M. Harper; Meghan Raymond; Walter W. Noll; Dorothy R. Belloni; Laura Therrien Duncan; Bernard F. Cole

Background Self-sampling for human papillomavirus (HPV) is useful for triage of ASCUS Papanicolaou (Pap) smears. Tampons with 10-second cervicovaginal cell exposure can detect HPV but appear to be less efficient than two consecutive swabs. Goal The purpose of this study was to evaluate increased vaginal tampon exposures for detecting high-risk HPV. Study Design This longitudinal cohort study followed women who self-sampled weekly with tampons for progressively longer periods of time. A tampon was inserted for 10 seconds at the office visit and 1 hour, 4 hours, and overnight for the three subsequent home samples. Two concurrent swabs were used with each tampon sampling for contemporaneous comparisons. The MY09/MY11 PCR primer system with reverse line blot detection strips was used to detect 18 distinct high-risk HPV types. Results Of the 309 tampons and 618 swabs used at home, 83% were returned. Among normal women, the 10-second tampon detected fewer with normal histology and high-risk HPV than did its swabs (P = 0.0412), but the 1-hour, 4-hour, and overnight tampons had high-risk-HPV detection rates equal to their swabs. In women with CIN, all tampons and swabs equally identified those with high-risk HPV. Conclusion Self-sampling for HPV detection is acceptable, feasible, and technically accurate for both tampons with longer cervicovaginal exposures and swabs. The choice of technique is dependent on the woman, her culture, and her clinician.


Clinical Endocrinology | 2005

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma

William B. Kinlaw; Sarah M. Scott; Robert A. Maue; Vincent A. Memoli; Robert D. Harris; Gilbert H. Daniels; Donna M. Porter; Dorothy R. Belloni; Edward T. Spooner; Manfred M. Ernesti; Walter W. Noll

Objective   We have identified a large kindred with multiple endocrine neoplasia 2A (MEN 2A) due to a mutation at RET codon 609 that results in a cysteine to serine substitution, a mutation previously identified in only one case in the literature. We characterized the clinical phenotype of the kindred and the biochemical mechanism of this new mutation.


Cancer Genetics and Cytogenetics | 1990

Hypodiploid, pseudodiploid, and normal karyotypes prevail in cytogenetic studies of medullary carcinomas of the thyroid and metastatic tissues

Doris H. Wurster-Hill; Olive S. Pettengill; Walter W. Noll; Sarah H. Gibson; Truls Brinck-Johnsen

Medullary carcinoma of the thyroid (MCT), often a dominantly inherited neoplasm, derived from intrathyroid C-cells of neural crest origin, is one of the solid tumors least studied cytogenetically. The cells are difficult to grow in culture, only two cell lines having ever been established. Cytogenetic studies of only 5 tumors have been reported previously. In this paper we report on the cytogenetic analyses of 8 specimens of primary and/or metastatic MCT tumor tissue from 6 patients with familial disease, including more recent metastatic tumors in lymph node and femur of a patient whose thyroid and earlier lymph node metastases were described previously. Some of these specimens were harvested sequentially over time. Hypodiploid or diploid modal numbers prevailed with normal, pseudodiploid, or hypodiploid karyotypes.


Cancer Genetics and Cytogenetics | 1988

Fragile sites and high-resolution chromosome studies in multiple endocrine neoplasia type 2A

Doris H. Wurster-Hill; Walter W. Noll; John T. Devlin; Richard W. Erbe; Sarah H. Gibson; Josiane Dossu

Affected individuals from four kindreds with multiple endocrine neoplasia type 2A syndrome (MEN-2A), were studied for the possible existence of a specific fragile site that might be associated with the MEN-2A gene. The chromosomes were also examined with high-resolution banding with particular emphasis on those chromosomes (#1, 10, 20, and 22) that have been implicated by previous studies from several laboratories as being associated with this disease. There was no evidence for a unique fragile site or a unique high-resolution banding pattern in subjects with MEN-2A. These findings, in combination with all previous cytogenetic studies, indicate that it is unlikely that current techniques will be useful in developing a simple cytogenetic test for this disease.


JAMA | 1996

The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis

Charis Eng; David G. Clayton; Isabelle Schuffenecker; Gilbert M. Lenoir; Gilbert J. Cote; Robert F. Gagel; Hans Kristian Ploos van Amstel; Cornelis J. M. Lips; Isamu Nishisho; Shin Ichiro Takai; Deborah J. Marsh; Bruce G. Robinson; Karin Frank-Raue; Friedhelm Raue; Feiyu Xue; Walter W. Noll; Cristina Romei; Furio Pacini; Monika Fink; Bruno Niederle; Jan Zedenius; Magnus Nordenskjöld; Paul Komminoth; Geoffrey N. Hendy; Hossein Gharib; Stephen N. Thibodeau; André Lacroix; Andrea Frilling; Bruce A.J. Ponder; Lois M. Mulligan


Psycho-oncology | 2003

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

Tim A. Ahles; Andrew J. Saykin; Walter W. Noll; Charlotte T. Furstenberg; Stephen J. Guerin; Bernard F. Cole; Leila A. Mott

Collaboration


Dive into the Walter W. Noll's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John T. Devlin

University of Vermont Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge